EGLN1 and colorectal carcinoma: To investigate how CAFs induce WARS2-IT1 and contribute to radioresistance in CRC, we conducted an RNA pull-down assay followed by mass spectrometry, identifying PHD2 as a binding partner for WARS2-IT1 (Fig. 4C).